PTH Induces Systemically Administered Mesenchymal Stem Cells to Migrate to and Regenerate Spine Injuries

Authors:

Abstract
No abstract available
Funding Information
  • Eli Lilly and Company
  • National Institutes of Health (P50 AR054041, R01DE019902)
  • California Institute for Regenerative Medicine (TR2-01780)

This publication has 53 references indexed in Scilit: